Indiana University School of Medicine (IUSM) researchers have found in
laboratory models that people's intake of vitamin B3 (niacin) can slow the progression of Alzheimer's disease. The findings of this study offer new possibilities for treating Alzheimer's disease. They recently published the results of the study in the journal Science Translational Medicine. They investigated how vitamin B3 alters the response of microglia to amyloid plaques in animal models of Alzheimer's disease. The researchers believe the results of this study could identify a potential new therapeutic target for Alzheimer's disease. In addition, it could adjust the treatment guidelines for Alzheimer's disease. This therapeutic strategy has great potential in clinical treatment.
What are the benefits of niacin?
Niacin interacts with highly selected HCAR2 receptors in the brain. HCAR2 receptors are present in immune cells associated with amyloid plaques. The researchers say that when niacin activates the receptor, these immune cells are stimulated by it to have beneficial effects on Alzheimer's disease.
The results of the study showed that niacin treatment reduced amyloid plaques in an animal model of Alzheimer's disease. It also improves cognition in animal models of Alzheimer's disease. These effects are all due to the HCAR2 receptor. The researchers also said that past epidemiological and niacin studies on Alzheimer's disease indicated that people with higher dietary intake of niacin had a lower risk of developing Alzheimer's disease. In clinical trials, niacin has also been used in the treatment of glioblastoma and Parkinson's disease.
What are the main food sources of niacin?
In general, few people develop niacin deficiency. Because it is present in the food of many animals and plants. These foods include pork, poultry, fish, beef, beef liver, beans, nuts, seeds, brown rice, grains, bread, bananas, and more.
For more detail, you can read this article.π
Miguel Moutinho, Shweta S. Puntambekar, Andy P. Tsai, Israel Coronel, Peter B. Lin, Brad T. Casali, Pablo Martinez, Adrian L. Oblak, Cristian A. Lasagna-Reeves, Bruce T. Lamb, Gary E. Landreth. The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer’s disease. Science Translational Medicine, 2022; 14 (637) DOI: 10.1126/scitranslmed.abl7634
https://www.hsph.harvard.edu/nutritionsource/niacin-vitamin-b3/
0 comments:
Post a Comment
Welcome to leave your comment.Ω©(⚙α΄⚙)ΫΆ